Some experts in the medical field are asking the government to deregulate buprenorphine, an addiction treatment drug, arguing that requiring providers to take an eight-hour X-waiver training course before administering the drug and submitting to subsequent audits by the Drug Enforcement Administration (DEA) has limited its availability in the medical community amid the opioid epidemic.

Read More >>